The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance
Open accessPublished version of a preprint
Abstract
Purpose: The measurement of mutations in pancreatic juice samples collected from the duodenum during endoscopic ultrasound (EUS) may improve the diagnostic evaluation of patients undergoing pancreatic surveillance. Our aim was to evaluate the accuracy of using pancreatic juice mutation concentrations to predict the presence and histologic grade of neoplasia in the pancreas. Experimental Design: Digital next-generation sequencing (NGS) of pancreatic juice DNA using a targeted 12-gene panel was performed on 67 patients undergoing pancreatic evaluation during EUS, including patients with pancreatic ductal adenocarcinoma, patients who subsequently underwent pancreatic resection for precursor lesions, patients undergoing surveillance for their familial/inherited susceptibility to pancreatic cancer, and normal pancreas disease controls. Results: Patients with pancreatic cancer or high-grade dysplasia as their highest grade lesion had significantly higher pancreatic juice mutation concentrations than all other subjects (mean/SD digital NGS score; 46.6 ± 69.7 vs. 6.2 ± 11.6, P = 0.02). Pancreatic juice mutation concentrations distinguished patients with pancreatic cancer or high-grade dysplasia in their resection specimen from all other subjects with 72.2% sensitivity and 89.4% specificity [area under the curve (AUC) = 0.872]. Mutant TP53/SMAD4 concentrations could distinguish patients with pancreatic cancer or high-grade dysplasia in their resection specimen from all other subjects with 61.1% sensitivity and 95.7% specificity (AUC = 0.819). Among 31 high-risk individuals under surveillance, 2 of the 3 individuals with most abnormal pancreatic juice mutation profiles also had the most abnormalities on pancreatic imaging. Conclusions: Pancreatic juice mutation analysis using digital NGS has potential diagnostic utility in the evaluation of patients undergoing pancreatic surveillance. Clin Cancer Res; 24(12); 2963–74. ©2018 AACR. See related commentary by Lipner and Yeh, p. 2713
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In passing, it also needs to be stated that, although blood remains the most commonly studied biospecimen for early detection, many of the analytes are also present in other proximate samples, including pancreatic juice,53,54 stool,55 urine,56,57 saliva,58 and pancreatic cyst fluid.59”
From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621 · cited 20×
“As the most important goal of pancreatic surveillance is to detect evidence of pancreatic cancer or high-grade dysplasia, patients were grouped into those with pancreatic cancer or high-grade dysplasia (PanIN-3 or in IPMN) versus all others (disease controls, those under surveillance, and those with low-grade dysplasi…”
BackgroundInfluentialVincent, A., Herman, J. M., Schulick, R., Hruban, R. H., & Goggins, M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62307-0 · Cited by 2,678
Self-citationInternational consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Tanaka, M., Fernández-del Castillo, C., Adsay, V., Chari, S., Falconi, M., Jang, J.-Y., Kimura, W., Levy, P., Pitman, M. B., Schmidt, C. M., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.04.004 · Cited by 2,354
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337
Integrated genomic characterization of pancreatic ductal adenocarcinoma
Raphael, B. J., Hruban, R. H., Aguirre, A. J., Moffitt, R. A., Yeh, J. J., Stewart, C., Robertson, A. G., Cherniack, A. D., Gupta, M., Getz, G., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.007 · Cited by 2,019
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
Kaufman, B., Shapira‐Frommer, R., Schmutzler, R. K., Audeh, M. W., Friedlander, M. L., Balmañà, J., Mitchell, G., Fried, G., Stemmer, S. M., Hubert, A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.2728 · Cited by 1,734
Direct detection of early-stage cancers using circulating tumor DNA
Phallen, J. A., Sausen, M., Adleff, V., Leal, A., Hruban, C., White, J. R., Anagnostou, V., Fiksel, J., Cristiano, S., Papp, E., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan2415 · Cited by 1,149
Detection and quantification of rare mutations with massively parallel sequencing
Kinde, I., Wu, J., Papadopoulos, N., Kinzler, K. W., & Vogelstein, B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105422108 · Cited by 1,144
Cited by
Sorted by citations
Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment
Wood, L. D., Canto, M. I., Jaffee, E. M., & Simeone, D. M. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.03.056 · Cited by 918
Self-citationGoggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., Bassi, C., Carrato, A., Farrell, J., Fishman, E. K., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319352 · Cited by 659
Self-citationStoffel, E. M., Brand, R. E., & Goggins, M. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.02.012 · Cited by 565
Self-citationCanto, M. I., Almario, J. A., Schulick, R. D., Yeo, C. J., Klein, A., Blackford, A., Shin, E. J., Sanyal, A., Yenokyan, G., Lennon, A. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.035 · Cited by 414
Self-citationThe Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival
Dbouk, M., Katona, B. W., Brand, R. E., Chak, A., Syngal, S., Farrell, J. J., Kastrinos, F., Stoffel, E. M., Blackford, A. L., Rustgi, A. K., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.00298 · Cited by 247
Self-citationArtificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review
Kenner, B., Chari, S. T., Kelsen, D., Klimstra, D. S., Pandol, S. J., Rosenthal, M., Rustgi, A. K., Taylor, J. A., Yala, A., Abul-Husn, N., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001762 · Cited by 158
Self-citationEarly detection of pancreatic cancer using DNA-based molecular approaches
Singhi, A. D., & Wood, L. D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00470-0 · Cited by 127
Abe, T., Blackford, A. L., Tamura, K., Ford, M., McCormick, P., Chuidian, M., Almario, J. A., Borges, M., Lennon, A. M., Shin, E. J., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01512 · Cited by 102
Self-citationPancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma
Nakamura, S., Sadakari, Y., Ohtsuka, T., Okayama, T., Nakashima, Y., Gotoh, Y., Saeki, K., Mori, Y., Nakata, K., Miyasaka, Y., et al. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07269-z · Cited by 96
Self-citationFischer, C. G., & Wood, L. D. (2018) · The Journal of Pathology · doi:10.1002/path.5154 · Cited by 95
Genetics of familial and sporadic pancreatic cancer
Wood, L. D., Yurgelun, M. B., & Goggins, M. G. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.039 · Cited by 91
Self-citationSWI/SNF component ARID1A restrains pancreatic neoplasia formation
Wang, S. C., Nassour, I., Xiao, S., Zhang, S., Luo, X., Lee, J., Li, L., Sun, X., Nguyen, L. H., Chuang, J.-C., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-315490 · Cited by 85
Greenhalf, W., Lévy, P., Gress, T. M., Rebours, V., Brand, R. E., Pandol, S., Chari, S. T., Jørgensen, M. T., Mayerle, J. V., Lerch, M. M., et al. (2020) · Pancreatology · doi:10.1016/j.pan.2020.05.011 · Cited by 83
Canto, M. I., Kerdsirichairat, T., Yeo, C. J., Hruban, R. H., Shin, E. J., Almario, J. A., Blackford, A. L., Ford, M., Klein, A. P., Javed, A. A., et al. (2019) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-019-04230-z · Cited by 82
Self-citationAbe, T., Koi, C., Kohi, S., Song, K. B., Tamura, K., Macgregor‐Das, A. M., Kitaoka, N., Chuidian, M., Ford, M., Dbouk, M. H., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.10.036 · Cited by 64
Self-citationLevink, I. J. M., Bruno, M. J., & Cahen, D. W. (2018) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-018-0190-2 · Cited by 53
Familial Pancreatic Cancer: Current Perspectives
Llach, J., Carballal, S., & Moreira, L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s172421 · Cited by 51
Dbouk, M., Brewer Gutierrez, O. I., Lennon, A. M., Chuidian, M., Shin, E. J., Kamel, I. R., Fishman, E. K., He, J., Burkhart, R. A., Wolfgang, C. L., et al. (2021) · Pancreatology · doi:10.1016/j.pan.2021.01.017 · Cited by 46
Self-citationOkada, T., Mizukami, Y., Ono, Y., Sato, H., Hayashi, A., Kawabata, H., Koizumi, K., Masuda, S., Teshima, S., Takahashi, K., et al. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-020-01724-5 · Cited by 44
Sagami, R., Yamao, K., Nakahodo, J., Minami, R., Tsurusaki, M., Murakami, K., & Amano, Y. (2021) · Cancers · doi:10.3390/cancers13050945 · Cited by 45
Bartsch, D. K., Krasser‐Gercke, N., Strauch, K., Wieboldt, R., Matthäi, E., Wagner, V., Rospleszcz, S., Schäfer, A., Franke, F. S., Mintziras, I., et al. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100295 · Cited by 36
Kulkarni, N. M., Mannelli, L., Zins, M., Bhosale, P., Arif‐Tiwari, H., Brook, O. R., Hecht, E. M., Kastrinos, F., Wang, Z. J., Soloff, E. V., et al. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02290-y · Cited by 33
Surveillance of high-risk individuals for pancreatic cancer with EUS and MRI: A meta-analysis
Kogekar, N., Diaz, K. E., Weinberg, A. D., & Lucas, A. L. (2020) · Pancreatology · doi:10.1016/j.pan.2020.10.025 · Cited by 35
Early Detection of Pancreatic Cancer: Current Advances and Future Opportunities
Lin, Z., Adeniran, E. A., Cai, Y., Qureshi, T. A., Li, D., Gong, J., Li, J., Pandol, S. J., & Jiang, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13071733 · Cited by 34
Pedro, B. A., & Wood, L. D. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191937 · Cited by 35
Chronic pancreatitis changes in high-risk individuals for pancreatic ductal adenocarcinoma
Thiruvengadam, S. S., Chuang, J., Huang, R. J., Girotra, M., & Park, W. G. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.08.029 · Cited by 26
Current status of molecular diagnostic approaches using liquid biopsy
Takahashi, K., Takeda, Y., Ono, Y., Isomoto, H., & Mizukami, Y. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-02024-4 · Cited by 26
Levink, I. J. M., Nesteruk, K., Visser, D., Sieuwerts, A. M., Fernandes, C. J. C., Jansen, M. P. H. M., van Driel, L. M. J. W., Poley, J., Peppelenbosch, M. P., Cahen, D. L., et al. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000939 · Cited by 24
Choi, M. H., Mejlænder-Andersen, E., Manueldas, S., Jellas, K. E., Steine, S. J., Tjensvoll, K., Sætran, H. A., Knappskog, S., Hoem, D., Nordgård, O., et al. (2019) · BMC Cancer · doi:10.1186/s12885-018-5195-7 · Cited by 26
Macgregor-Das, A. M., Yu, J., Tamura, K., Abe, T., Suenaga, M., Shindo, K., Borges, M. W., Koi, C., Kohi, S., Sadakari, Y., et al. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.02.010 · Cited by 25
Self-citationSuenaga, M., Fujii, T., Yamada, S., Hayashi, M., Shinjo, K., Takami, H., Niwa, Y., Sonohara, F., Shimizu, D., Kanda, M., et al. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08990-w · Cited by 23
Self-citationScreening for pancreatic cancer has the potential to save lives, but is it practical?
Mazer, B. L., Lee, J. W., Roberts, N. J., Chu, L. C. H., Lennon, A. M., Klein, A. P., Eshleman, J. R., Fishman, E. K., Canto, M. I., Goggins, M., et al. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2217354 · Cited by 24
Self-citationThe role of biomarkers in the early detection of pancreatic cancer
Goggins, M. (2024) · Familial Cancer · doi:10.1007/s10689-024-00381-4 · Cited by 28
Self-citationChallenges of early detection of pancreatic cancer
Shen, M. J., Jamali, A., & Katona, B. W. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191942 · Cited by 24
Current Screening Strategies for Pancreatic Cancer
Vaněk, P., Urban, O., Zoundjiekpon, V., & Falt, P. (2022) · Biomedicines · doi:10.3390/biomedicines10092056 · Cited by 21
He, H., Stein, E. V., Konigshofer, Y., Forbes, T. D., Tomson, F. L., Garlick, R. K., Yamada, E., Godfrey, T. E., Abe, T., Tamura, K., et al. (2019) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2019.03.006 · Cited by 20
Self-citationSaba, H., & Goggins, M. (2022) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2022.06.006 · Cited by 20
Self-citationNikas, I. P., Mountzios, G., Sydney, G. I., Ioakim, K. J., Won, J., & Papageorgis, P. (2022) · Cancers · doi:10.3390/cancers14020397 · Cited by 22
Visser, I. J., Levink, I. J. M., Peppelenbosch, M. P., Fuhler, G. M., Bruno, M. J., & Cahen, D. L. (2022) · Pancreatology · doi:10.1016/j.pan.2022.06.260 · Cited by 21
The biology of pancreatic cancer morphology
McDonald, O. G. (2021) · Pathology · doi:10.1016/j.pathol.2021.09.012 · Cited by 20
Inherited Pancreatic Cancer Syndromes and High-Risk Screening
Biller, L. H., Wolpin, B. M., & Goggins, M. (2021) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2021.06.002 · Cited by 19
Self-citationChiba, K., Hata, T., Mizuma, M., Masuda, K., Aoki, S., Takadate, T., Kawaguchi, K., Nakagawa, K., Morikawa, T., Motoi, F., et al. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-10997-w · Cited by 17
Smith, L. M., Mahoney, D. W., Bamlet, W. R., Yu, F., Liu, S., Goggins, M., Darabi, S., Majumder, S., Wang, Q.-L., Coté, G. A., et al. (2024) · Pancreatology · doi:10.1016/j.pan.2024.10.012 · Cited by 17
Self-citationKawabata, H., Miyazawa, Y., Sato, H., Okada, T., Hayashi, A., Iwama, T., Fujibayashi, S., Goto, T., Sasajima, J., Takauji, S., et al. (2019) · Endoscopy International Open · doi:10.1055/a-1034-7700 · Cited by 16
Aunan, J. R., Jamieson, N. B., & Søreide, K. (2019) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v11.i12.1092 · Cited by 15
Sagami, R., Mizukami, K., Nishikiori, H., Sato, T., Fujiwara, S., Kawamoto, Y., Ome, Y., Honda, G., Horiguchi, S., Sato, K., et al. (2024) · Pancreatology · doi:10.1016/j.pan.2024.06.006 · Cited by 14
Fulmer, C. G., Park, K., Dilcher, T. L., Ho, M., Mirabelli, S., Alperstein, S. A., Hissong, E. M., Pittman, M. E., Siddiqui, M. T., Heymann, J. J., et al. (2020) · Cancer Cytopathology · doi:10.1002/cncy.22315 · Cited by 13
Molecular Approaches Using Body Fluid for the Early Detection of Pancreatic Cancer
Satoh, K. (2021) · Diagnostics · doi:10.3390/diagnostics11020375 · Cited by 12
The role of endoscopic ultrasound in the detection of pancreatic lesions in high-risk individuals
Overbeek, K. A., Cahen, D. L., & Bruno, M. J. (2024) · Familial Cancer · doi:10.1007/s10689-024-00380-5 · Cited by 11
Potjer, T. P. (2021) · Gut · doi:10.1136/gutjnl-2021-324739 · Cited by 10
Takano, S., Fukasawa, M., & Enomoto, N. (2022) · Digestive Endoscopy · doi:10.1111/den.14371 · Cited by 10
Pathological and molecular diagnoses of early cancer with bile and pancreatic juice
Kuwatani, M., & Sakamoto, N. (2022) · Digestive Endoscopy · doi:10.1111/den.14348 · Cited by 10
Matsuda, Y., Esaka, S., Suzuki, A., Hamashima, Y., Imaizumi, M., Matsukawa, M., Fujii, Y., Aida, J., Takubo, K., Ishiwata, T., et al. (2018) · Cytopathology · doi:10.1111/cyt.12653 · Cited by 7
Current paradigm and futuristic vision on new-onset diabetes and pancreatic cancer research
Moreland, R., Arredondo, A., Dhasmana, A., Dhasmana, S., Shabir, S., Siddiqua, A., Banerjee, B., Yallapu, M. M., Behrman, S. W., Chauhan, S. C., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1543112 · Cited by 6
Pulvirenti, A., Barbagallo, M., Putignano, A. R., Pea, A., Polidori, R., Upstill‐Goddard, R., Cortese, N., Kunderfranco, P., Brunelli, L., Simone, G. D., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1405612 · Cited by 6
Screening for Pancreatic Cancer—Is There Hope?
Lennon, A. M., Hruban, R. H., & Klein, A. P. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.3323 · Cited by 7
Self-citationAchterberg, F. B., Mulder, B. G. S., Janssen, Q. P., Koerkamp, B. G., Hol, L., Quispel, R., Bonsing, B. A., Vahrmeijer, A. L., van Eijck, C. H. J., Roos, D., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280939 · Cited by 5
Shin, D. W., Cho, J., Cho, S., Youn, Y., & Hwang, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-19631-1 · Cited by 5
Tavano, F., Latiano, A., Palmieri, O., Gioffreda, D., Latiano, T. P., Gentile, A., Tardio, M., Latiano, T. P., Gentile, M., Terracciano, F., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158436 · Cited by 4
Choi, M. H., Tjora, E., Forthun, R. B., Engjom, T., Ræder, H., Hovland, R., & Molven, A. (2021) · Pancreatology · doi:10.1016/j.pan.2021.09.010 · Cited by 4
Cytologic, histologic, and clinical correlation of minor mutations in pancreatic cysts
Kwan, M. C., Pitman, M. B., & Zhang, M. L. (2025) · Cancer Cytopathology · doi:10.1002/cncy.22935 · Cited by 3
Proteomic insights into early pancreatic ductal adenocarcinoma biology and screening
Huang, Y., Sun, C., Gao, X., Zhai, S., Wang, G., & Zhang, F. (2025) · Discover Oncology · doi:10.1007/s12672-025-03317-1 · Cited by 3
Pancreatic Cancer Screening among High-risk Individuals
Turner, K. M., & Patel, S. H. (2024) · Surgical Clinics of North America · doi:10.1016/j.suc.2024.03.002 · Cited by 3
Progress report: familial pancreatic cancer
Mintziras, I., & Bartsch, D. K. (2019) · Familial Cancer · doi:10.1007/s10689-019-00125-9 · Cited by 3
Ma, H., Qammar, S., Wang, J.-M., Zhai, A., Li, F., & Hu, H. (2026) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70281 · Cited by 2
Okada, T., Mizukami, Y., Hayashi, A., Kawabata, H., Sato, H., Kawamoto, T., Goto, T., Taniue, K., Ono, Y., Karasaki, H., et al. (2020) · Suizo · doi:10.2958/suizo.35.302 · Cited by 2
Sequencing Pancreatic Juice: Squeezing the Most Out of Surveillance
Lipner, M. B., & Yeh, J. J. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0215 · Cited by 2
Capurso, G. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619839528 · Cited by 2
Causal relationship analysis of MRI measurements of major human internal organs and liver disease
Wu, H., Zhou, D., Zhu, J., & Tu, J. (2025) · European journal of medical research · doi:10.1186/s40001-025-02529-z · Cited by 1
Hopley, P. J., Peysner, R., Boughey, A., Kewlani, B., Smith, A. M., Aithal, G. P., Oppong, K. W., Finch-Jones, M., Hamady, Z., Athwal, T., et al. (2026) · European Journal of Cancer · doi:10.1016/j.ejca.2026.116592 · Cited by 1
Pancreatic Atrophy: A Narrative Review and Surgical Interpretation
Fujino, R., Okada, K.-I., Masugi, Y., Iwasaki, E., & Mori, M. (2026) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.70230 · Cited by 1
Genomic medicine for the early detection of pancreatic cancer
Sato, H., Takahashi, K., & Mizukami, Y. (2022) · Suizo · doi:10.2958/suizo.37.29
Screening of Hereditary Pancreatic Cancer
Goggins, M. (2023) · Wiley eBooks · doi:10.1002/9781119876007.ch130
Self-citationPancreatic cancer - diagnosis, risk factors and treatment. Literature review
Olczyk, K. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.17.01.016
The Role of Markedly Elevated Cyst Carcinoembryonic Antigen in Risk-Stratifying Pancreatic Cysts
Bloomfield, G. C., Yusin, G., Radkani, P., Namgoong, J., Haddad, N., Chalhoub, W. M., Fishbein, T., & Winslow, E. R. (2025) · Journal of Surgical Research · doi:10.1016/j.jss.2025.01.027
Jones, A. R., Kannan, A., Ley, D. A., Ramirez, O. R., Sheth, M., Murimwa, G. Z., Abbas, A., Deverakonda, A. N., Bishop, C., Coleman, V. L., et al. (2025) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2025.11.025
From bench to bedside: pancreatic juice as a platform for biomarker discovery in pancreatic disease
Siddappa, P. K., Kong, N., Lee, A. A., Jiang, Y., & Park, W. G. (2026) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2025.216
Letter to the Editor: Tumor markers in pancreatic juice: How and when to collect?
Losurdo, G., Gesualdo, M., Iannone, A., Castellano, F., Mezzapesa, M., & Principi, M. (2026) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.121112
Okumura, K., Kozaka, K., & Kobayashi, S. (2026) · Digestive Diseases and Sciences · doi:10.1007/s10620-026-10065-x
Sato, M., Kitahata, Y., Nakamura, Y., Motobayashi, H., Takemoto, N., Nakai, T., Hyo, T., Ueno, M., Hayami, S., Miyamoto, A., et al. (2026) · Annals of Surgical Oncology · doi:10.1245/s10434-026-20286-z · Cited by 1
Okabayashi, T., Tabuchi, M., Tokumaru, T., Uemura, S., & Tamura, S. (2026) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2026.2750981
Metadata
- Authors
- Suenaga, M., Yu, J., Shindo, K., Tamura, K., Almario, J. A., Zaykoski, C., Witmer, P. D., Fesharakizadeh, S., Borges, M., Lennon, A.-M., Shin, E.-J., Canto, M. I., & Goggins, M.
- Affiliations
- Johns Hopkins University (US)
- 2Center for Inherited Disease Research (CIDR), Baltimore, Maryland.
- Corresponding author
- Goggins, Michael
- ORCID
- Venue
- Clinical Cancer Research
- Published
- 2018-06-14
- Volume
- 24
- Issue
- 12
- Pages
- 2963-2974
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- PMC
- PMC6435263
- OpenAlex
- W2782485244
- Cited by
- 81
- References
- 51
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 7 · 2023: 6 · 2022: 9 · 2021: 10 · 2020: 9 · 2019: 14 · 2018: 8
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P50CA062924, R01CA176828)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK089502)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Keywords
- pancreatic juice, circulating tumor DNA, pancreatic cancer surveillance, pancreatic dysplasia, histologic grade prediction, TP53 mutation, SMAD4 mutation, endoscopic ultrasound, pancreatic ductal adenocarcinoma, pancreatic precursor lesions
- MeSH terms
- Cell-Free Nucleic Acids, Aged, Aged, 80 and over, DNA Mutational Analysis, Female, Humans, Male, Middle Aged, Mutation, Pancreas, Pancreatic Juice, Pancreatic Neoplasms, Population Surveillance, ROC Curve, Biomarkers, Tumor, High-Throughput Nucleotide Sequencing, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
